Kina 68858-20-8 Fmoc-L-Val-OH Mea hana a hale hana |Jiayinglai

68858-20-8 Fmoc-L-Val-OH

ʻO ka wehewehe pōkole:

Ka nana aku	ʻO ka pauka keʻokeʻo keʻokeʻo
MF	C20H21NO4
MW	339.39
Maemae	98+

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Kūlana halihali
Hiki i ka wela maʻamau

Manaʻo i ke ʻano hoʻouna
Ma ka lewa Ma ka aina Ma ke kai

Kūlana mālama:
E mālama i kahi pōʻeleʻele, Inert ea, lumi wela

Ola ola
Ma kahi o 2 makahiki

Ka nui o ke kauoha liʻiliʻi:
1kg （kūkākūkā）

palapala hōʻoia:COA, wahi hehee, Hoʻololi kikoʻī [α]_D²⁰

E hoʻouna mākou i nā ʻikepili āu e makemake ai.Hiki iā ʻoe ke ʻike i ka ʻikepili ma mua ma ke ʻano he kuhikuhi.

No nā huahana maʻamau, hoʻouna mākou i ka ʻikepili hou ma hope o ka puka ʻana mai.

Nā huaʻōlelo like

FMOC-L-Valine

N-FMOC-VAL-OH

N-FMOC-L-VAL

N-FMOC-L-VALINE N-(9-FLUORENYLMETHOXYCARBONYL)-L-VALINE

N-9-FLUORENYLMETHYLOXYCARBONYL-L-VALINE

N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-VALINE

N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-L-VALINE N-ALPHA-FMOC-L-VALINE

Hoʻopili i loko

Hoʻohana pinepine ʻia lākou no ka hoʻopili ʻana i ka pauka.Pili ia i nā koi o nā mea kūʻai aku.No laila, e haʻi mai iā mākou i kāu koi ma mua o ka hoʻopaʻa ʻana inā loaʻa iā ʻoe nā noi kūikawā.

kāʻei waho

1kg a 25kg He paʻakikī ka paʻi waho.A he mea paʻakikī ke ʻoki a hōʻino.Hiki iā ia ke pale pono i kāu mau huahana.

Nā noi

ʻO 68858-20-8 Fmoc-L-Val-OH kekahi o nā mea waena Abaloparatide.

ʻO ka mea mua, hana ʻo Abaloparatide i ka hoʻoponopono ʻana i ka metabolism a hoʻoikaika i ka hoʻokumu ʻana i ka iwi ma o ka hoʻāla koho ʻana i ke ala hōʻailona o PTH1 type 1 receptor (PTH1R).Hoʻonui nui ia i ka iwi iwi a hoʻemi i ka pilikia o ka haki.Ua hōʻike nā haʻawina i nā kāne me ka osteoporosis, ʻo ka mālama ʻana me ka Abaloparatide e hoʻomaikaʻi nui a hoʻomaikaʻi wikiwiki i ka BMD (bone mineral density) o ka iwi kuamoʻo, ka ʻāʻī femoral, a me ka ʻāʻī āpau i hoʻohālikelike ʻia me kahi placebo.

ʻO ka lua, ua'āponoʻiaʻo Abaloparatide no ke kūʻaiʻana e ka US Food and Drug Administration (FDA) no ka mālamaʻana i ka osteoporosis i nā wāhine postmenopausal e pilikia ana i ka haʻihaʻi a iʻole i paneʻole i nā mea lapaʻau'ē aʻe.Eia kekahi, ua hōʻike ʻia ka lāʻau lapaʻau no nā kāne makua nona ka testosterone replacement therapy ʻaʻole i hōʻike ʻia e hōʻemi i ka pilikia o ka mea maʻi i nā haʻihaʻi vertebral a me ka hoʻonui ʻana i ka ikaika o ka iwi ma ka ʻūhā a me ka ʻoki ʻole.

I ka hoʻohana ʻana iā Abaloparatide, ʻo ka mea i ʻōlelo ʻia ʻo 80mcg i lawelawe ʻia ma lalo o ka ʻili i hoʻokahi manawa i kēlā me kēia lā.Inā lawa ʻole ka ʻai ʻana o ka mea maʻi, pono e hoʻonui ʻia ka calcium a me ka huaora D. Ma mua o ka lawelawe ʻana, e hoʻomaʻemaʻe a maʻemaʻe ka syringe lāʻau a me ka nila.

Ma keʻano holoʻokoʻa, ua hōʻike ʻia ʻo Abaloparatide i ka maikaʻi i ka mālama ʻana i ka osteoporosis a ua hoʻohana nui ʻia i ka hana lapaʻau.

huahana pili

L-Val-OH	D-Val-OH	N-Me-D-Val-OH	Pht-Val-OH
AC-Val-OH	Boc-L-Val-OH	Boc-D-Val-OH	Boc-N-Me-Val-OH
Fmoc-D-Val-OH	Cbz-L-Val-OH	Cbz-D-Val-OH	Cbz-Val-Val-OH

No ke aha e koho ai iā mākou

1. No ka MOQ: Hiki iā mākou ke hoʻololi e like me kāu koi.
2. E pili ana i ka hāpana: Pono ka hāpana i ka uku hōʻailona, hiki ke lawe i ka ukana e hōʻiliʻili aiʻole hiki iāʻoe ke uku iā mākou ma mua.
3. Mold workshop, hiki ke hoʻopilikino ʻia e like me ka helu o nā hiʻohiʻona.
4. Hāʻawi mākou i ka lawelawe maikaʻi loa.Ke hana nei kekahi hui kūʻai akamai iā ʻoe.
5. E pili ana i ka hoʻololi: E ʻoluʻolu e leka uila a kamaʻilio mai iaʻu ma kou ʻoluʻolu.

Mua: 84624-17-9 Fmoc-D-Val-OH

Aʻe: 166108-71-0 Fmoc-AEEA-OH

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou